| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/13/2011 | EP2342974A2 Composition for improving membrane composition and functioning of cells |
| 07/13/2011 | EP2342569A2 Screening method for identifying patients at risk of adverse hepatologic events |
| 07/13/2011 | EP2342203A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 07/13/2011 | EP2342187A1 Glycoside derivatives and uses thereof |
| 07/13/2011 | EP2342178A1 Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof |
| 07/13/2011 | EP2341914A2 Modulation of toll-like receptor 3 expression by antisense oligonucleotides |
| 07/13/2011 | EP2341902A1 Glucoside derivatives and uses thereof as sglt inhibitors |
| 07/13/2011 | EP2102197B1 5-([1,3,4]oxadiazol-2-yl)-1h-indazol and 5-([1,3,4]thiadiazol-2-yl)-1h-indazol derivatives as sgk inhibitors for the treatment of diabetes |
| 07/13/2011 | EP2098598B1 Screening method for prophylactic and/or therapeutic agent for disease accompanied by hepatitis c |
| 07/13/2011 | EP2086532B1 Use for treating obesity and diabetes |
| 07/13/2011 | EP1934245B1 Y2 selective receptor agonists for therapeutic interventions |
| 07/13/2011 | EP1543158B1 Regulated aptamer therapeutics |
| 07/13/2011 | EP1509489B1 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| 07/13/2011 | EP1395128B2 Acid controlled viscosity fibre system and uses thereof |
| 07/13/2011 | CN1907390B Oral liquid for treating diabetes dry-thirsty and its preparing process and application |
| 07/13/2011 | CN1774178B Pet food composition for regulating body weight and preventing obesity and related disorders in pets |
| 07/13/2011 | CN1175976B Arachidonic acid and method for production and use thereof |
| 07/13/2011 | CN102124029A Method of diagnosis of infection by mycobacteria and reagents therefor |
| 07/13/2011 | CN102123729A Use of hsp70 as a regulator of enzymatic activity |
| 07/13/2011 | CN102123699A Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor |
| 07/13/2011 | CN102121023A Mutant human plasminogen kringle5, preparation method and application thereof |
| 07/13/2011 | CN102120781A Preparation and application of novel oral insulin nanoparticles |
| 07/13/2011 | CN102120724A 5-amino-4-hydroxy-7-benzyl-8-methylnonanamide derivative, preparation method thereof and application thereof in medicines |
| 07/13/2011 | CN102120035A Novel targeted medicament for treating metabolic syndrome by targeting at white adipose tissues |
| 07/13/2011 | CN102120034A Novel targeted medicament targeted to brown adipose tissues for treating obesity |
| 07/13/2011 | CN102119959A Preparation for adjusting blood pressure and blood fat and preventing cardiovascular and cerebrovascular diseases and preparation method thereof |
| 07/13/2011 | CN102119953A Application of euphorbia humifusa wild extract |
| 07/13/2011 | CN102119942A Bombax malabaricum DC. leaf total phenol extract and preparation method thereof, and application of extract in treatment of type-2 diabetes mellitus |
| 07/13/2011 | CN102119931A Novel metformin hydrochloride slow-releasing tablet and preparation method thereof |
| 07/13/2011 | CN102119776A Dried orange peel extract and preparation method and use thereof |
| 07/13/2011 | CN102119774A Health-care food suitable for patient with type 2 diabetes mellitus |
| 07/13/2011 | CN102119732A Milk powder with function of treating diabetes and preparation method thereof |
| 07/13/2011 | CN101417987B DPP-IV inhibitor with sulfonamide formyl piperazine structure |
| 07/13/2011 | CN101396543B Pure traditional Chinese medicine preparation for treating cardio-cerebrovascular disease |
| 07/13/2011 | CN101175494B Prophylactic/therapeutic agent for abnormalities of sugar/lipid metabolism |
| 07/13/2011 | CN101171002B Novel use of liver X receptor agonists |
| 07/13/2011 | CN101166742B Novel lactam compound |
| 07/12/2011 | US7977506 Amino acid for delivering active materials; bioavailability |
| 07/12/2011 | US7977469 biosynthesis of long chain polyunsaturated fatty acids like DHA (docosahexaenoic acid, 22:6, n-3); stress, diabetes, cancer, inflammatory disorders, and cardiovascular disorders |
| 07/12/2011 | US7977466 C-glycoside derivatives and salts thereof |
| 07/12/2011 | US7977455 Analogues of GLP-1 |
| 07/12/2011 | US7977353 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 07/12/2011 | US7977350 CCR1 antagonists and methods of use therefor |
| 07/12/2011 | US7977337 Quinoline derivatives and their use as 5-HT6 ligands |
| 07/12/2011 | US7977329 Obesity therapy; using 3-benzoazepine compound |
| 07/12/2011 | US7977328 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes |
| 07/12/2011 | US7977316 Prevention and treatment of amyloidogenic diseases |
| 07/12/2011 | US7977310 Method for reducing cardiovascular morbidity and mortality in prediabetic patients and patients with type 2 diabetes |
| 07/12/2011 | US7977059 17867, a novel human aminopeptidase |
| 07/12/2011 | US7976869 Fenofibrate tablets |
| 07/12/2011 | US7976853 Process for producing coated preparation |
| 07/12/2011 | US7976836 Treatment of stroke using placental stem cells |
| 07/12/2011 | CA2526957C Long lasting insulin derivatives and methods thereof |
| 07/12/2011 | CA2500649C Substituted arylhexadienoic acids and esters thereof, their use in the treatment of dyslipidaemia, diabetes and atherosclerosis, and processes for their preparation |
| 07/12/2011 | CA2481767C Severe sepsis preventive therapeutic agent |
| 07/12/2011 | CA2470721C Superoxide dismutase mimics for the treatment of ocular disorders and diseases |
| 07/12/2011 | CA2463505C Low-calcemic oxime analogs of 1.alpha.,25-dihydroxy vitamin d3 |
| 07/12/2011 | CA2458455C Pharmaceutical compositions comprising colloidal silicon dioxide |
| 07/12/2011 | CA2449150C Tricyclic compounds useful as angiotensin ii agonists |
| 07/12/2011 | CA2422617C Tripeptidyl peptidase inhibitors |
| 07/12/2011 | CA2389685C Novel heterocyclic compounds and their use as medicaments |
| 07/12/2011 | CA2352286C Intracellular targeted delivery of compounds by 70 kd heat shock protein |
| 07/12/2011 | CA2341336C Elongase genes and uses thereof |
| 07/12/2011 | CA2312274C Isolated dna encoding human h3 histamine receptor |
| 07/12/2011 | CA2291514C Methods for evaluating tissue morphogenesis and activity |
| 07/07/2011 | WO2011081942A1 Activation and activators of sirt5 |
| 07/07/2011 | WO2011081915A2 Methods for treating erectile dysfunction in patients with insulin-dependent diabetes |
| 07/07/2011 | WO2011081493A2 Pharmaceutical composition comprising metformin and rosuvastatin |
| 07/07/2011 | WO2011081488A2 Composition for treatment of obesity using wheat bran extract or active ingredient isolated therefrom |
| 07/07/2011 | WO2011081231A1 Composition and functional food using polygonum cuspidatum butanol extract or ethyl acetate extract for treating and preventing obesity |
| 07/07/2011 | WO2011081229A1 Pharmaceutical composition for inhibiting angiogenesis |
| 07/07/2011 | WO2011081222A1 Method for manufacturing pancreatic-hormone-producing cells |
| 07/07/2011 | WO2011081173A1 Tetracyclic compound |
| 07/07/2011 | WO2011081118A1 Pharmaceutical composition for oral administration |
| 07/07/2011 | WO2011081117A1 Solid pharmaceutical composition for oral administration |
| 07/07/2011 | WO2011080755A1 Fused nitrogen heterocyclic compounds, process of preparation and uses thereof |
| 07/07/2011 | WO2011080751A2 α4β2 NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS |
| 07/07/2011 | WO2011080277A1 Thieno [2,3-b] pyridinedione activators of ampk and therapeutic uses thereof |
| 07/07/2011 | WO2011080276A1 Pharmaceutical combinations comprising a dpp-4 inhibitor and a 1,3-diphenylprop-2-en-1-one derivative |
| 07/07/2011 | WO2011079778A1 3-(3-aminopiperidin-1-yl)-5-oxo-1,2,4-triazine derivates as dipeptidyl peptidase iv(dpp-iv) inhibitors |
| 07/07/2011 | WO2011079772A1 Method for preparation of 2,5-disubstituted thiophene compound |
| 07/07/2011 | WO2011079356A1 Carbon nanotube conjugate for inhibiting pathogenic infection structures in plants |
| 07/07/2011 | WO2011051342A8 IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS |
| 07/07/2011 | WO2011017488A3 Combination of a selective ppar-gamma modulator and an incretin for the treatment of diabetes and obesity |
| 07/07/2011 | WO2011014707A3 Therapeutic agents for reducing parathyroid hormone levels |
| 07/07/2011 | WO2011013999A3 Composition containing chitooligosaccharide for recovering from fatigue |
| 07/07/2011 | WO2010077854A8 High affinity human antibodies to pcsk9 |
| 07/07/2011 | US20110166233 Compounds for the treatment of metabolic disorders |
| 07/07/2011 | US20110166228 Composition |
| 07/07/2011 | US20110166226 Process for obtaining an extract rich in rosmarinic acid (ra) from the plant origanum vulgare and its use for the treatment of diabetes |
| 07/07/2011 | US20110166224 Diacylglycerol rich fats, oils and functional foods |
| 07/07/2011 | US20110166218 Methods for micronization of hydrophobic drugs |
| 07/07/2011 | US20110166195 Method for the formation of megamitochondria |
| 07/07/2011 | US20110166178 Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylase |
| 07/07/2011 | US20110166176 Compounds and compositions as modulators of gpr119 activity |
| 07/07/2011 | US20110166175 7-azaindole derivatives |
| 07/07/2011 | US20110166174 Compounds modulating c-kit and c-fms activity and uses therefor |
| 07/07/2011 | US20110166167 Bicyclic heterocycle derivatives and methods of use thereof |
| 07/07/2011 | US20110166165 Bicyclic heterocycle derivatives and use thereof as gpr119 modulators |
| 07/07/2011 | US20110166159 Compounds that modulate intracellular calcium |